Tell us about your search experience on the TGA website - complete our short survey
TGA Provisional Approval of Moderna COVID-19 vaccine to include 12-17 years age group
Published
Related content
- TGA provisionally approves Moderna's COVID-19 vaccineOn 9 August 2021 the TGA granted provisional approval to Moderna Australia Pty Ltd in relation to the COVID-19 vaccine, Spikevax (elasomeran), for individuals aged 18 years and over.
- Moderna's COVID-19 vaccine (SPIKEVAX) provisionally approved for use in individuals 6 years and olderThe TGA has provisionally approved the Moderna CoVID-19 vaccine, SPIKEVAX, for use in individuals 6 years and older.
- TGA provisionally approves Moderna’s COVID-19 vaccine for use as a booster dose in individuals 12 years and olderOn 19 October 2022, the TGA provisionally approved Moderna's COVID-19 vaccine, SPIKEVAX (elasomeran), for use as a booster dose in individuals aged 12 years and older.